A detailed history of Octagon Capital Advisors LP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 2,576,200 shares of TNYA stock, worth $5 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
2,576,200
Previous 2,854,000 9.73%
Holding current value
$5 Million
Previous $14.9 Million 46.5%
% of portfolio
1.85%
Previous 2.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.72 - $4.99 $755,616 - $1.39 Million
-277,800 Reduced 9.73%
2,576,200 $7.99 Million
Q1 2024

May 15, 2024

BUY
$2.88 - $6.8 $8.22 Million - $19.4 Million
2,854,000 New
2,854,000 $14.9 Million

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $80.2M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.